TRBC2 encodes a specific region of the T-cell receptor beta-2 chain38 and has been identified as a promising biomarker for the distinction of multiple cancer types, including breast cancer, colorectal cancer, glioblastoma, hepatobiliary cancer, lung cancer and pancreatic cancer and so on39. This evidence concerns the gene TRBC2 and lung carcinoma.